Calif. Appeal Panel Affirms Ax Of Zantac Prop 65 Claims
A California appeals court has refused to revive a nonprofit's attempt to force generic antacid drug makers and sellers to comply with Proposition 65's labeling requirement, which warns of cancer risks...To view the full article, register now.
Already a subscriber? Click here to view full article